Pregnancy associated with lupus anticoagulant and heparin induced thrombocytopenia: management with a low molecular weight heparinoid

Thromb Res. 1991 Apr;62(1-2):23-9. doi: 10.1016/0049-3848(91)90665-j.

Abstract

The management of pregnant patients with coagulopathies and heparin induced thrombocytopenia is difficult and poorly defined. We report the case of a patient who was treated with a low molecular weight heparinoid. The treatment was complicated by the delayed occurrence of thrombocytopenia and a thrombotic event. This is the first report of thrombocytopenia caused by heparinoid. It is possible that this complication could have been avoided by a shorter duration of treatment with heparinoid and the use of Vitamin K antagonists during the second trimester of pregnancy.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Blood Coagulation Disorders / complications
  • Blood Coagulation Disorders / drug therapy*
  • Blood Coagulation Disorders / immunology
  • Blood Coagulation Factors / analysis
  • Blood Coagulation Factors / immunology
  • Chondroitin Sulfates*
  • Dermatan Sulfate*
  • Female
  • Glycosaminoglycans / therapeutic use*
  • Heparin / adverse effects*
  • Heparinoids / therapeutic use*
  • Heparitin Sulfate*
  • Humans
  • Lupus Coagulation Inhibitor
  • Pregnancy
  • Pregnancy Complications, Hematologic / chemically induced
  • Pregnancy Complications, Hematologic / drug therapy*
  • Pregnancy Complications, Hematologic / immunology
  • Thrombocytopenia / chemically induced
  • Thrombocytopenia / complications
  • Thrombocytopenia / drug therapy*

Substances

  • Blood Coagulation Factors
  • Glycosaminoglycans
  • Heparinoids
  • Lupus Coagulation Inhibitor
  • Dermatan Sulfate
  • Heparin
  • Chondroitin Sulfates
  • Heparitin Sulfate
  • danaparoid